Matches in Nanopublications for { ?s ?p "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP573083.RATIvbyYdaSAVaqBK0PYkGxc26iVJXBlYkHS4_M5ujAxI130_assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573083.RATIvbyYdaSAVaqBK0PYkGxc26iVJXBlYkHS4_M5ujAxI130_provenance.
- NP573955.RAT3YyK9ArbWnPHYDDfNiIMnDOXmvfCDQwP8hSq_uuN90130_assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573955.RAT3YyK9ArbWnPHYDDfNiIMnDOXmvfCDQwP8hSq_uuN90130_provenance.
- assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance.
- NP931424.RAsLfkDcUp0nMavdmDsPTF-llWiUy19gKO3rC1brRp42c130_assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931424.RAsLfkDcUp0nMavdmDsPTF-llWiUy19gKO3rC1brRp42c130_provenance.
- NP931419.RA-kRFP9GRIXtkTonBxVnJ56sRp3TCWHK6bjEl3OW1mAA130_assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931419.RA-kRFP9GRIXtkTonBxVnJ56sRp3TCWHK6bjEl3OW1mAA130_provenance.
- NP931421.RA1TjsYjIAgUPbcurmqhgMzAF97GSQzAsPH9O4gv3i2C8130_assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931421.RA1TjsYjIAgUPbcurmqhgMzAF97GSQzAsPH9O4gv3i2C8130_provenance.